GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (OTCPK:RCDTF) » Definitions » E10

Recordati SpA (Recordati SpA) E10 : $1.54 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Recordati SpA E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Recordati SpA's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.442. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $1.54 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Recordati SpA's average E10 Growth Rate was 7.90% per year. During the past 3 years, the average E10 Growth Rate was 13.90% per year. During the past 5 years, the average E10 Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Recordati SpA was 15.00% per year. The lowest was 6.80% per year. And the median was 13.60% per year.

As of today (2024-05-22), Recordati SpA's current stock price is $51.60. Recordati SpA's E10 for the quarter that ended in Dec. 2023 was $1.54. Recordati SpA's Shiller PE Ratio of today is 33.51.

During the past 13 years, the highest Shiller PE Ratio of Recordati SpA was 47.87. The lowest was 24.51. And the median was 37.25.


Recordati SpA E10 Historical Data

The historical data trend for Recordati SpA's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA E10 Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 1.34 1.45 1.61 1.54

Recordati SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.63 1.71 1.67 1.54 -

Competitive Comparison of Recordati SpA's E10

For the Drug Manufacturers - General subindustry, Recordati SpA's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Shiller PE Ratio falls into.



Recordati SpA E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Recordati SpA's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.442/119.7000*119.7000
=0.442

Current CPI (Dec. 2023) = 119.7000.

Recordati SpA Quarterly Data

per share eps CPI Adj_EPS
201403 0.279 99.907 0.334
201406 0.260 100.093 0.311
201409 0.258 99.814 0.309
201412 0.219 99.721 0.263
201503 0.268 99.814 0.321
201506 0.276 100.279 0.329
201509 0.264 100.000 0.316
201512 0.242 99.814 0.290
201603 0.349 99.600 0.419
201606 0.308 99.900 0.369
201609 0.320 100.100 0.383
201612 0.277 100.300 0.331
201703 0.401 101.000 0.475
201706 0.375 101.100 0.444
201709 0.415 101.200 0.491
201712 0.391 101.200 0.462
201803 0.510 101.800 0.600
201806 0.435 102.400 0.508
201809 0.411 102.600 0.480
201812 0.406 102.300 0.475
201903 0.497 102.800 0.579
201906 0.444 103.100 0.515
201909 0.419 102.900 0.487
201912 0.612 102.800 0.713
202003 0.588 102.900 0.684
202006 0.462 102.900 0.537
202009 0.435 102.300 0.509
202012 0.471 102.600 0.550
202103 0.512 103.700 0.591
202106 0.675 104.200 0.775
202109 0.502 104.900 0.573
202112 0.485 106.600 0.545
202203 0.509 110.400 0.552
202206 0.277 112.500 0.295
202209 0.427 114.200 0.448
202212 0.359 119.000 0.361
202303 0.635 118.800 0.640
202306 0.536 119.700 0.536
202309 0.393 120.300 0.391
202312 0.442 119.700 0.442

Add all the adjusted EPS together and divide 10 will get our e10.


Recordati SpA  (OTCPK:RCDTF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Recordati SpA's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=51.60/1.54
=33.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Recordati SpA was 47.87. The lowest was 24.51. And the median was 37.25.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Recordati SpA E10 Related Terms

Thank you for viewing the detailed overview of Recordati SpA's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA (Recordati SpA) Business Description

Traded in Other Exchanges
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (Recordati SpA) Headlines

From GuruFocus

Recordati: Isturisa® (Osilodrostat) Approved In The U.S.

By PRNewswire PRNewswire 03-09-2020